<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25080547</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-790X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>2014</Volume>
            <PubDate>
              <Year>2014</Year>
              <Month>Jul</Month>
              <Day>30</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMJ case reports</Title>
          <ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bickerstaff's encephalitis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">bcr2014205336</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2014-205336</ELocationID>
        <Abstract>
          <AbstractText>Bickerstaff's brainstem encephalitis is a rare syndrome defined by the triad of ophthalmoplegia, ataxia and decreased consciousness. It is considered to be a variant of Miller Fisher syndrome and Guillain-Barré syndrome but is differentiated from the two by the presence of central nervous system involvement, commonly in the form of impaired consciousness. We present an unusual case of Bickerstaff's encephalitis, where the patient presented with pseudobulbar affect.</AbstractText>
          <CopyrightInformation>2014 BMJ Publishing Group Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Horton</LastName>
            <ForeName>Emma</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krishnamoorthy</LastName>
            <ForeName>Sanjay</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Acute Medicine and General Internal Medicine, Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reynolds</LastName>
            <ForeName>Lucy</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, St George's Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>07</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMJ Case Rep</MedlineTA>
        <NlmUniqueID>101526291</NlmUniqueID>
        <ISSNLinking>1757-790X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005732">Gangliosides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001259" MajorTopicYN="N">Ataxia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003244" MajorTopicYN="N">Consciousness Disorders</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004660" MajorTopicYN="N">Encephalitis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005732" MajorTopicYN="N">Gangliosides</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009886" MajorTopicYN="N">Ophthalmoplegia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25080547</ArticleId>
        <ArticleId IdType="pmc">PMC4120029</ArticleId>
        <ArticleId IdType="doi">10.1136/bcr-2014-205336</ArticleId>
        <ArticleId IdType="pii">bcr-2014-205336</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Koga M.
A nationwide survey of patients with Bickerstaff brainstem encephalitis: diversity of underlying mechanism. Rinsho Shinkeigaku
2013;53:1322–4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24291974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koga M.
Bickerstaff brainstem encephalitis: epidemiology, diagnosis, and therapy. Nihon Rinsho
2013;71:898–903</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23777102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odaka M, Yuki N, Yamada M, et al. 
Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome. Brain
2003;126(Pt 10):2279–90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12847079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickerstaff E.
Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. BMJ
1957;ii:1384–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1973653</ArticleId>
            <ArticleId IdType="pubmed">13436795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickerstaff E, Cloake PCP.
Mesencephalitis and rhombencephalitis. BMJ
1951;2:77–81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2069534</ArticleId>
            <ArticleId IdType="pubmed">14848512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickerstaff ER.
Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis. BMJ
1957;1:1384–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1973653</ArticleId>
            <ArticleId IdType="pubmed">13436795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ropper AH.
The CNS in Guillain-Barré syndrome. Arch Neurol
1983;40:397–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6860172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odaka M, Yuki N, Hirata K.
Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry
2001;70:50–5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1763462</ArticleId>
            <ArticleId IdType="pubmed">11118247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakerley BR, Soon D, Chan YC, et al. 
Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia. J Neurol Neurosurg Psychiatry
2013;84:1206–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23564757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimozono K, Shimono K, Kusunoki S.
Case of Bickerstaff brainstem encephalitis associated with spindle coma and decorticate posture. Rinsho Shinkeigaku
2012;52:656–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22989900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saito K, Shimizu F, Koga M, et al. 
Blood-brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study. J Neurol Neurosurg Psychiatry
2013;84:756–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23584494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito M, Kuwabara S, Odaka M, et al. 
Bickerstaff's brainstem encephalitis and Fisher syndrome from a continuous spectrum: clinical analysis of 581 cases. J Neurol
2008;255:674–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18274803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba A, Kusunoki S, Obata H, et al. 
Serum anti GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology
1993;43:1911–17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8413947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willison HJ, Veitch J.
Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol
1994;50:159–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8120137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JK, Bae JS, Kim DS, et al. 
Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol
2014;10:94–100</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4017025</ArticleId>
            <ArticleId IdType="pubmed">24829594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchwald B, Dudel J, Toyka KV.
Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome. Ann N Y Acad Sci
1998;841:659–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9668311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba A, Kusunoki S, Obata H, et al. 
Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology
1993;43:1911–17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8413947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuwabara S, Asahina M, Nakajima M, et al. 
Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol
1999;45:533–6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10211482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu JX, Willison HJ, Pedrosa-Domellöf F.
Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci
2009;50:3226–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19255160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roos R, Soliven B, Goldenberg F, et al. 
An elderly patient with Bickerstaff brainstem encephalitis and transient episodes of brainstem dysfunction. Arch Neurol
2008;65:821–4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18541805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuki N.
Anti-ganglioside antibody and neuropathy: review of our research. J Peripher Nerv Syst
1998;3:3–18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10959233</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
